Cytodyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards

This is to clarify the recent conference call and counter misleading information on it by shorters etc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.